Table 1. Psoriasis Data Sets.
Study | GEO Accession | Tissue Type* | # Samples in Study | # Samples in Analysis | Array Type | Labeling Method | Reference |
Yao | GSE14905 | LS | 32 | 25 | U133_Plus_2 | cRNA | Yao et al. 2008 |
NL | 28 | 25 | |||||
Reischl | GSE6710 | LS | 13 | 13 | U133A | cRNA | Reischl et al. 2007 |
NL | 13 | 13 | |||||
Zaba (GSE11903) | GSE11903 | LS | 15 | 14 | U133A_2 | cRNA | Zaba et al. 2009 |
NL | 15 | 14 | |||||
Week12 LS | 15 | 8 | |||||
Gudjonsson | GSE13355 | LS | 39 | 37 | U133_Plus_2 | cRNA | Gudjonsson et al. 2010 |
Low | NL | 39 | 37 | ||||
Gudjonsson | LS | 19 | 19 | ||||
High | NL | 19 | 19 | ||||
Zaba (Amgen) | GSE41664 | LS | 15 | 15 | U133_Plus_2 | cDNA | in-house |
NL | 15 | 15 | |||||
Week12 LS | 9 | 8 | |||||
Asterand | GSE41664 | LS | 14 | 14 | U133_Plus_2 | cDNA | in-house |
NL | 14 | 14 | |||||
NCT00867100 | GSE41664 | LS | 24 | 24 | U133_Plus_2 | cDNA | in-house |
NL | 24 | 24 |
LS = lesional, NL = non-lesional.